Viewing Study NCT07138833


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-26 @ 1:25 AM
Study NCT ID: NCT07138833
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-24
First Post: 2025-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)
Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module